Barrett's oesophagus (BO) is a complicated condition at the gastroesophageal junction in which normal squamous epithelium is changed to columnar and leads to oesophageal adenocarcinoma (OA). In the past decades, the prevalence of Barrett's disease and mortality rate of adenocarcinoma has significantly increased throughout the word. Data has shown that molecular pathogenesis of disease has not been clearly identified. However, a wide-range and successful administration of probiotics in cancer and gastrointestinal diseases has lead to the investigation into the possible inhibitory role of probiotics in oesophageal cancer. This study was conducted to evaluate the inhibitory effect of probiotics on the expression of biomarkers in an in vitro model. Two different Barrett's oesophageal cell lines were selected to co-culture with B. longum and Lactobacillus acidophilus to measure expression of IL-18, TNFa, p53 (tumour suppressor gene), cyclooxygenase 2 and CDX1 (caudal type homeobox 1) genes. In addition, two different aspects of probiotic administration, therapeutic and prophylactic test were also examined. Results showed that micro-organisms could inhibit expression of biomarkers and therapeutic culture conditions were more effective than prophylactic tests. The results obtained suggest that it is possible to incorporate the administration of probiotics in BO and OA prevention.
INTRODUCTION
Barrett's oesophagus (BO) is well recognized as a precursor of oesophageal adenocarcinoma (OA), which is usually caused by gastroesophageal reflux disease (GORD). In BO, normal squamous epithelium is replaced by columnar intestinal epithelium because of GORD effects. It is known that progression of BO to OA includes sequence of metaplasia-dysplasia-adenocarcinoma, which is created by the effect of various factors and multiple pathways including environmental and genetic factors. The incidences of both Barrett's and oesophageal cancer have risen in the world particularly in the Western world and the UK by variation between 1/52 and 1/694, respectively (HvidJensen et al., 2011; Werner & Laßmann, 2012; Zimmerman, 2014) . Subsequently, different studies have evaluated a range of putative factors that might support risk of progression of BO to OA. Current evidence suggests that progression of Barrett's disease is associated with the changes in bacterial population in GORD, BO and OA patients (Blackett et al., 2013) . It has been suggested that Gram-negative bacteria (Campylobacter concisus) may initiate the progression of BO (Mozaffari namin et al., 2015) Despite the availability of several diagnostic techniques and treatment protocols, there are conflicting results on screening and surveillance of BO and OA survival (Lim & Fitzgerald, 2013; Sharma et al., 2013; Thrift et al., 2014) . The use of probiotics has been established in the prevention of carcinogenic diseases. Probiotics are described as live micro-organisms applied in adequate amounts for beneficial use in order to strengthen the ordinary defence system and protect the gastrointestinal epithelium against pathogenic bacteria. Probiotics have been used successfully in cases of infant diarrhoea, food allergies, ulcerative colitis, colonic cancer, Crohn's disease and inflammatory bowel disease (Furrie et al., 2005; Steed et al., 2010; Rijkers et al., 2011; Quigley, 2012) . The positive effects of probiotics on gastrointestinal diseases had motivated the investigation into the possible influence of micro-organisms on Barrett's transformation. This study planned to determine the consequences of probiotics on the expression of key biomarkers that contribute to the progression of BO to OA. These molecular markers were identified as being modulated by the effect of C. concisus in our previous study that identified C. concisus as a putative pathogen in the transformation of BO to OA (Mozaffari namin et al., 2015) . This study indicates evidence on the inhibitory effect of probiotics to prevent progression of BO to OA in an in vitro model which might help new exploration into OA treatment.
METHODS
Bacterial strains and culture conditions. B. longum and Lactobacillus acidophilus strains were selected as probiotics and the strain Campylobacter concisus ATCC13826 was selected as a pathogen and was used previously by Mozaffari namin et al. (2015) . The identity of the probiotic strains was verified by 16S rRNA gene sequence analyses (DNA analysis lab at Ninewells Hospital) and a search using BLAST confirmed the strains to be B. longum KACC 91563 and L. acidophilus NCFM. B. longum was grown on Wilkins-Chalgren agar (WC; Oxoid) agar and L. acidophilus was grown on MRS agar (SigmaAldrich). Before each experiment B. longum was subcultured in WC broth and incubated anaerobically for 24 h at 37 uC and under 10 % H 2 , 10 % CO 2 and 80 % N 2 . L. acidophilus was maintained in MRS broth and incubated aerobically for 24 h at 37 uC. Organisms were then centrifuged (2500 g, 25 min), washed once with PBS, counted in a haemocytometer and resuspended to a concentration of 3610 7 bacteria or microbes ml
21
.
Tissue culture. Pre-neoplastic BO cell lines including CP-A (nondysplastic metaplasia) and CP-D (high-grade dysplastic) were selected for co-culturing with the probiotics as described previously (Mozaffari namin et al., 2015) . In brief, Barrett's cell lines were maintained in keratinocyte serum-free medium (Invitrogen) with supplements. Cells were then treated at 5610 5 cells ml 21 in six-well plates (Corning) in 3 ml complete medium. The cells were grown to a semiconfluent monolayer and utilized for co-culturing with the probiotic strains. All cell lines were incubated at 37 uC in 5 % CO 2 in a humidified atmosphere.
Co-culture with probiotics. Confluent BO cell lines (CP-A and CP-D) in a six-well plate were incubated with 3610 7 microorganisms ml 21 for 1, 3, 5 and 7 h at 37 uC in 5 % CO 2 and 95 % O 2 ; the medium was without antibiotics. To check the clear effect of the probiotics on the expression of biomarkers, co-cultures were completed in three different steps. First, probiotics were co-cultured with the BO cell lines. Second, CP-A and CP-D cell lines were infected with C. concisus and were then added probiotics for therapeutic effect. Finally, confluent cell lines were engaged with probiotics and then covered by C. concisus for prophylactic testing. All supernatants were aspirated off and the monolayer cells were collected, followed by a short centrifugation step, and the cellular pellet was maintained at 280 uC. All co-culture experiments were conducted in triplicate and a culture medium without bacteria was used as a negative control.
mRNA extraction and quantitative PCR. The mRNA gene expression of selected biomarkers was detected following co-culture with probiotics and assessed against the GAPDH housekeeping gene by extraction of mRNA, synthesis of cDNA using primer sets described in Table 1 and quantified by real-time quantitative PCR (qPCR) as described previously (Mozaffari namin et al., 2015) . DNA standards for quantification of DNA were prepared and qPCR was then performed by using an iCycler real-time PCR Detection System (Bio-Rad Laboratories) by iQ SYBR Green Super mix (Bio-Rad) with appropriate annealing temperature (Table 1) . Testing was performed in triplicate and the results were analysed as the mean of three independent experiments.
Statistical analysis. Data were reported as mean±SEM. Repeatedmeasurement two-way ANOVA analysis with Bonferroni post-hoc test was used to compare the difference between groups. P values of ,0.05 were considered as statistically significant. GraphPad Prism version 4 was applied to analyse the data.
RESULTS

Effect of probiotics on biomarkers
B. longum influenced the expression of biomarkers in nondysplastic BO cell line (CP-A) as shown in Table 2 . There was a significant decrease in the expression of all molecular markers compared with control groups, whereas a remarkable effect in the presence of the probiotic B. longum was observed in the suppression of TNFa (3264±4.53 to 69.5±1.91), p53 (1670±5.44 to 743±3.68) and cyclooxygenase 2 (COX2, 41±3.36 to 17.5±1.42); expression of CDX1 had been blocked. There was also a reduction, as a consequence of the effect of L. acidophilus, on the CP-A cell line in which all biomarkers declined except for a slight increase in IL-18 expression. In contrast, the probiotics had a considerable influence on the expression of biomarkers in CP-D cell lines in which B. longum substantially decreased TNFa (5224±4.54 to 22.5±4.73), IL-18 (327±1.23 to 157±8.05) and COX2 (12432±9.48 to 123±6.41) levels and CDX1 was inhibited. The presence of L. acidophilus also reduced the expression of markers whereas p53 dropped from 4066±1.43 to 2290±5.71, TNFa from 6482±1.22 to 605±5.14 and IL-18 from 83±3.9 to 69±5.3 (Table 3 ).
The prophylactic tests revealed that both B. longum and L. acidophilus enhanced the expression of p53, but there was a sharp decrease in TNFa levels (134±5.2 to 25.5±3.05 and 29875±4.92 to 91±5.01, respectively; Table 4 ) and B. longum reduced the expression of IL-18, which was the opposite to that observed with L. acidophilus. On the other hand, therapeutic tests showed that the influence of probiotics on the expression of biomarkers was more considerable than the prophylactic tests such that a significant reduction was seen by the effect of B. longum on the expression of TNFa (2726±1.07 to 50±2.53), p53 (20531±5.11 to 9820±2.69), although there was a slight increase in IL-18 (6.15±1.1 to 9.6±3.8) expression, while L. acidophilus did not influence the expression of markers (Table 5) .
DISCUSSION
Transformation of BO to OA is associated with a large number of molecular and cellular alternations along with bacteria colonization (Russo et al., 2013) . BO biofilm has generated the possibility of involving microbes in BO progression and therefore probiotics might influence and restrain molecular modifications of BO movements. Studies have shown that beneficial micro-organisms have positive effects in controlling gastrointestinal diseases (Macfarlane et al., 2008; Girardin & Seidman, 2011; Weng & Walker, 2013) . Subsequently, this study investigated the possible role of B. longum and L. acidophilus in the inhibition of those biomarkers that contribute to BO transformation such as IL-18, TNFa, p53, COX2 and CDX1. The results obtained herein demonstrated that probiotics have a significant inhibitory effect.
Activation of each biomarker provides a chance for early tumour detection at the different stages of disease (Nguyen et al., 2010) . For example, inflammatory cytokines are released in oesophageal epithelial injuries, which induce and activate NF-kB and interleukins (1b, 4, 8, 10, 12, and 18 ) to interconnect in a multiple pathway (Babar et al., 2012) . In addition, COX2, which is a tumour-promoting factor, is induced by TNFa and growth factors to accelerate tumourgenesis (Allen et al., 2012; Hashimoto, 2012) . These procedures continue during carcinogenesis in association with the activation of p53 and also the induction of CDX genes. Thus, preventing progression of these multi-mechanism pathways could provide an opportunity to inhibit BO progression. In addition, studies have shown that probiotics can affect the release of specific cytokines from different cell populations, even lamina propria immune cells, to participate in rising mucosal immunity. This can happen in gastrointestinal epithelial cells by the effect of beneficial bacteria through modulation of pro-and anti-inflammatory cytokines. Therefore, the characteristics of probiotics support the preventive and therapeutic effects of beneficial microorganisms (Grover et al., 2012) . Table 2 . mRNA fold differences in gene expression of biomarkers on CP-A cell line co-cultured with bifidobacteria and lactobacillus at 3 h Results are the mean±SEM from three independent experiments compared with non-stimulated controls, analysed by two-way ANOVA followed by Bonferroni post-hoc test analysis. ND, Not determined. Results from this study illustrate that the expression of biomarkers was inhibited markedly in metaplastic and dysplastic Barrett's cell lines. These reductions were observed in the CP-D cell line more than the CP-A cell line. Interesting results were achieved when we used bifidobacteria and lactobacillus against C. concisus therapeutically and prophylactically. The findings showed that the therapeutic test was more effective than the prophylactic test on the expression of markers, whereas the influence of bifidobacteria on suppression of TNFa and IL-18 was obvious in the therapeutic condition. Furthermore, B. longum inhibited the expression of markers in the dysplastic cell line more than the non-dysplastic cell line compared with lactobacillus. Similarly, Khailova et al. (2010) showed that B. bifidum had a positive effect on controlling necrotizing enterocolitis as it had blocked intestinal apoptosis through the inhibition of COX2. An additional study demonstrated that probiotics could significantly downregulate the expression of COX2 into two intestinal epithelial cell lines (Colo320 and SW480) (Otte et al., 2009) . Thus, the results of COX2 suppression presented in this study also confirmed that expression of COX2 has been reduced significantly in both cell lines.
Evaluation of the CDX1 gene, which is responsible for intestinal proteins and transformation, revealed considerable results. It is believed that there is a close relationship between inflammatory responses and transcription factors since replacement of damaged tissues normally starts by cell proliferation. Subsequently, chronic inflammation can persuade unrestrained proliferation, which leads to the production of unwanted proteins as a result of CDX genes or even p53 gene (Makita et al., 2013) . Since apoptosis is usually programmed by p53 to disregard death or abnormal cells in the cell cycle by binding to TNF receptors and Fas, any disruption in this pattern will results in unwanted cells. Thus, blocking or reducing the effect of p53 and CDXs in the progression of BO could downregulate the risk of OA (Fichter et al., 2011; Madsen, 2012) .
In this regard, current evidence on the expression of CDX1 in IPEC-1 cell lines showed that Saccharomyces cerevisiae had no effect on the expression of transcription factors (CDXs) (Zanello et al., 2011) . Findings from this study also confirmed that CP-A and CP-D cell lines had no impact on the expression of CDX1 when treated with B. longum; similar results were also experimented with L. acidophilus.
Evidence for regulating important cell cycle organizer, p53, were experienced considerable recession. Bifidobacteria suppressed the expression of p53 in the metaplastic cell line more than lactobacillus (even in the dysplastic cell lines). Additionally, the inhibitory effect of B. longum on p53 in the therapeutic setup culture was more significant than the prophylactic format. In the same way, a recent study revealed that L. acidophilus and L. casei increased the apoptosisinduction capacity in a colorectal cancer cell line in the presence of 5-fluorouracil (Baldwin et al., 2010) . This is Table 3 . mRNA fold differences in gene expression of biomarkers on CP-D cell line co-cultured with bifidobacteria and lactobacillus at 3 h
Results are the means±SEM from three independent experiments compared with non-stimulated controls, analysed by two-way ANOVA followed by Bonferroni post-hoc test analysis. ND, Not determined. Table 4 . mRNA fold differences in gene expression of biomarkers on CP-D cell line co-cultured with bifidobacteria and lactobacillus at 3 h (prophylactic test)
Results are the mean±SEM from three independent experiments compared with non-stimulated controls, analysed by two-way ANOVA followed by Bonferroni post-hoc test analysis. The precise mechanism by which probiotics inhibit the progression of the disease is unclear; however, studies have demonstrated that they can prevent bacterial colonization by blocking adhesion receptors (Ng et al., 2009; Smith et al., 2012) , enhance mucosal IgA responsibilities and expression of tight junction proteins (Madsen, 2012) , produce beneficial chemical products (bacteriocins), restrict bacterial translocation, increase epithelial barrier function and improve the gut immune system (Macfarlane & Cummings, 2002; Floch et al., 2011; Quigley, 2012) . Current reports established that probiotics could have inhibited cell proliferation such as Bacillus polyfermenticus, which adheres and restrains growth of colon cancer cells (Lee et al., 2007) and B. adolescentis, which restricted proliferation of Caco-2, SW 480 and HT-29 cell lines. Furthermore, bifidobacteria and lactobacillus modified cellular morphology and decreased the expression of TNFa (Kim et al., 2008; Yazdi et al., 2010; Soltan Dallal et al., 2012; Kun et al., 2013) . Lactobacillus GG reduced the production of polyamine in HGC-27 and DLD-1 cancer cell lines (Zhu et al., 2011) . Thus, probiotics can have anti-tumour properties by using toll-like receptors (TLRs), which have been recognized as the first site of interaction between bacteria and the host cells. Probiotic-mediated protection is both beneficial and detrimental; TLR-4, which damages the intestinal epithelium while TLR-2 reacts probiotic-mediated protection. Activation and participation of TLRs by probiotics against the progression of disease could be exploited to regulate apoptosis, block prostaglandin production, reduce cytokine effects and activate IL-12 to induce immune system (Khailova et al., 2010; Akatsu et al., 2012) . Moreover, they reduce reactive oxygen species (Zhu et al., 2011; Khan et al., 2012) , decrease mutagenic and genotoxic substances (nitrosamines) and cancer promoting enzymes (Malaguarnera et al., 2012) . Additionally, probiotics can compete with pathogens for binding sites and replace them from attached zones, increase their colonization ability by inducing epithelial cells to secrete mucus and express microorganism-associated molecular patterns to compete with pathogens for attachment (Madsen, 2012; Bermudez-Brito et al., 2012) . Results from this study showed that probiotics inhibited C. concisus attachment and its invasion system to downregulate the pathogenic effect of this organism. This is possible either by occupation of epithelial cell signalling pathways, obstruction of cell adhesion molecules or prevention of inducing cytokines via damaged cells. Subsequently, the reduction in the expression of selected biomarkers suggests that BO progression can be prevented or reduced through the effects of probiotics.
Conclusion
One of the main concerns of researchers is to determine the pathogenesis of Barrett's adenocarcinoma and its treatment. The use of probiotics in controlling some major disorders and cancers motivated this study to test the influence of probiotics on the progression of BO to OA in a cell culture model. The results obtained indicated that the strains of probiotics used herein have considerable inhibitory effects on the selected biomarkers tested, the beneficial micro-organisms reduced the expression of molecular markers and therapeutic testing was found to be more effective than prophylactic testing. Therefore, our in vitro model highlights the possibility of administering probiotics for the prevention of BO to OA. 
